Protein, cell and gene therapies for rare skin disorders

被引:0
|
作者
Del Rio, M. [1 ,2 ]
机构
[1] Univ Carlos III Madrid UC3M, CIEMAT, Madrid, Spain
[2] Univ Carlos III Madrid UC3M, Dept Bioengn, Madrid, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A28 / A28
页数:1
相关论文
共 50 条
  • [21] Emerging therapies for rare bleeding disorders - FV, FX
    Peyvandi, F.
    HAEMOPHILIA, 2015, 21 : 8 - 9
  • [22] When promising therapies are out of reach: Ethical responsibilities of stakeholders in gene therapy trials for rare disorders
    Major, Rami M.
    Yavarow, Zollie
    MOLECULAR THERAPY, 2025, 33 (01) : 30 - 31
  • [23] Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry
    Mavilio, F.
    GENE THERAPY, 2017, 24 (09) : 590 - 592
  • [24] Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry
    F Mavilio
    Gene Therapy, 2017, 24 : 590 - 592
  • [25] Stem Cell Therapies in Retinal Disorders
    Garg, Aakriti
    Yang, Jin
    Lee, Winston
    Tsang, Stephen H.
    CELLS, 2017, 6 (01)
  • [26] Stem cell therapies for muscle disorders
    Tedesco, Francesco S.
    Cossu, Giulio
    CURRENT OPINION IN NEUROLOGY, 2012, 25 (05) : 597 - 603
  • [27] Gene Therapies for Monogenic Autism Spectrum Disorders
    Weuring, Wout
    Geerligs, Jeroen
    Koeleman, Bobby P. C.
    GENES, 2021, 12 (11)
  • [28] An overview of gene therapies in the pipeline for ocular disorders
    Desideri, L. Ferro
    Vagge, A.
    Nicolo, M.
    Traverso, C. E.
    DRUGS OF THE FUTURE, 2021, 46 (05) : 383 - 390
  • [29] Gene-based therapies for neuromuscular disorders
    Zanoteli, Edmar
    Franca Jr, Marcondes Cavalcante
    Marques Jr, Wilson
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2024, 82 (06)
  • [30] A Mouse Model Resource to Test Gene and Cell-Based Therapies for Peroxisomal Disorders
    Hacia, Joseph G.
    Arayan, Lauren T.
    Braverman, Nancy E.
    Zuberi, Aamir R.
    MOLECULAR THERAPY, 2023, 31 (04) : 324 - 324